Residual Inflammatory Risk-Guided colcHicine in Elderly Trial

NCT06025071 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention
Multivessel Coronary Artery Disease
Elderly Patients
C-Reactive Protein

Interventions

DRUG: colchicine

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital